Latest | F'cast | |
---|---|---|
Div Yield | 0.9% | 0.0% |
Div Cover | 3.0 | 2.9 |
Op Mrgn | 3.9% | 12.4% |
ROCE | 8.5% |
Latest | F'cast | |
---|---|---|
P/E | 37.5 | 32.5 |
PEG | 0.5 | n/a |
Pr/Revenue | 2.9 | 1.9 |
Pr/Book | 4.8 |
Latest | F'cast | |
---|---|---|
Revenue | 12.8% | -18.2% |
PBT | n/a | 1107.8% |
EPS | 73.4% | -15.0% |
DPS | -21.3% | -35.3% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-20 | 213.60 | 2.20 | 98.60¢ | 58.2 | 6.5 | +9% | 34.50¢ | 0.6% |
30-Sep-21 | 248.30 | (35.60) | 60.60¢ | 43.3 | n/a | -38% | 44.90¢ | 1.7% |
30-Sep-22 | 263.50 | 6.00 | 54.70¢ | 27.8 | n/a | -10% | 44.90¢ | 3.0% |
30-Sep-23 | 243.80 | (20.20) | 40.30¢ | 20.7 | n/a | -26% | 29.60¢ | 3.5% |
30-Sep-24 | 275.00 | 2.30 | 69.90¢ | 23.6 | 0.3 | +73% | 23.30¢ | 1.4% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 303.75 | 37.53 | 59.44p | 32.6 | n/a | -15% | 20.36p | 0.0% |
30-Sep-26 | 323.60 | 45.10 | 79.79p | 24.3 | 0.7 | +34% | 22.86p | 0.0% |
30-Sep-27 | 343.97 | 51.22 | 91.67p | 21.1 | 1.4 | +15% | 25.32p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Interim Dividend Currency Exchange Rate | 13-Aug-2025 | 16:59 | RNS |
Holding(s) in Company | 11-Aug-2025 | 16:47 | RNS |
Directors'/PDMR Shareholdings | 07-Aug-2025 | 15:10 | RNS |
Drug film probe | 22-Apr-2008 | Sun |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
05-Aug-25 | Buy | Rich Cashin | 2,214.00p | 6 | £132.84 |
05-Aug-25 | Buy | Jos Sclater | 2,214.00p | 7 | £154.98 |
07-Jul-25 | Buy | Rich Cashin | 1,988.00p | 8 | £159.04 |
Currency | UK Pounds |
Share Price | 1,936.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2,180.00 |
52 Week Low | 1,206.00 |
Volume | 79,005 |
Shares Issued | 30.26m |
Market Cap | £585.80m |
Beta | 0.00 |
RiskGrade | 186 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 07-Aug-25 | 06-Feb-25 |
Paid | 05-Sep-25 | 07-Mar-25 |
Amount | 7.60¢ | 16.10¢ |
Time | Volume / Share Price |
16:35 | 5,575 @ 1,930.00p |
16:35 | 25,626 @ 1,936.00p |
16:35 | 11 @ 1,936.00p |
16:35 | 370 @ 1,936.00p |
16:35 | 504 @ 1,936.00p |
Chair | Bruce Thompson |
CFO | Rich Cashin |
You are here: research